Cargando…

Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children

BACKGROUND: Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Kay, Gemma Louise, Millard, Andrew, Sergeant, Martin J., Midzi, Nicholas, Gwisai, Reggis, Mduluza, Takafira, Ivens, Alasdair, Nausch, Norman, Mutapi, Francisca, Pallen, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482744/
https://www.ncbi.nlm.nih.gov/pubmed/26114287
http://dx.doi.org/10.1371/journal.pntd.0003861
_version_ 1782378499653238784
author Kay, Gemma Louise
Millard, Andrew
Sergeant, Martin J.
Midzi, Nicholas
Gwisai, Reggis
Mduluza, Takafira
Ivens, Alasdair
Nausch, Norman
Mutapi, Francisca
Pallen, Mark
author_facet Kay, Gemma Louise
Millard, Andrew
Sergeant, Martin J.
Midzi, Nicholas
Gwisai, Reggis
Mduluza, Takafira
Ivens, Alasdair
Nausch, Norman
Mutapi, Francisca
Pallen, Mark
author_sort Kay, Gemma Louise
collection PubMed
description BACKGROUND: Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs. uninfected children. METHODS: Stool DNA from 139 children aged six months to 13 years old; with S. haematobium infection prevalence of 27.34% was extracted at baseline. 12 weeks following antihelminthic treatment with praziqunatel, stool DNA was collected from 62 of the 139 children. The 16S rRNA genes were sequenced from the baseline and post-treatment samples and the sequence data, clustered into operational taxonomic units (OTUs). The OTU data were analysed using multivariate analyses and paired T- test. RESULTS: Pre-treatment, the most abundant phyla were Bacteroidetes, followed by Firmicutes and Proteobacteria respectively. The relative abundance of taxa among bacterial classes showed limited variation by age group or sex and the bacterial communities had similar overall compositions. Although there were no overall differences in the microbiome structure across the whole age range, the abundance of 21 OTUs varied significantly with age (FDR<0.05). Some OTUs including Veillonella, Streptococcus, Bacteroides and Helicobacter were more abundant in children ≤ 1 year old compared to older children. Furthermore, the gut microbiome differed in schistosome infected vs. uninfected children with 27 OTU occurring in infected but not uninfected children, for 5 of these all Prevotella, the difference was statistically significant (p <0.05) with FDR <0.05. PZQ treatment did not alter the microbiome structure in infected or uninfected children from that observed at baseline. CONCLUSIONS: There are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment.
format Online
Article
Text
id pubmed-4482744
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44827442015-06-29 Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children Kay, Gemma Louise Millard, Andrew Sergeant, Martin J. Midzi, Nicholas Gwisai, Reggis Mduluza, Takafira Ivens, Alasdair Nausch, Norman Mutapi, Francisca Pallen, Mark PLoS Negl Trop Dis Research Article BACKGROUND: Several infectious diseases and therapeutic interventions cause gut microbe dysbiosis and associated pathology. We characterised the gut microbiome of children exposed to the helminth Schistosoma haematobium pre- and post-treatment with the drug praziquantel (PZQ), with the aim to compare the gut microbiome structure (abundance and diversity) in schistosome infected vs. uninfected children. METHODS: Stool DNA from 139 children aged six months to 13 years old; with S. haematobium infection prevalence of 27.34% was extracted at baseline. 12 weeks following antihelminthic treatment with praziqunatel, stool DNA was collected from 62 of the 139 children. The 16S rRNA genes were sequenced from the baseline and post-treatment samples and the sequence data, clustered into operational taxonomic units (OTUs). The OTU data were analysed using multivariate analyses and paired T- test. RESULTS: Pre-treatment, the most abundant phyla were Bacteroidetes, followed by Firmicutes and Proteobacteria respectively. The relative abundance of taxa among bacterial classes showed limited variation by age group or sex and the bacterial communities had similar overall compositions. Although there were no overall differences in the microbiome structure across the whole age range, the abundance of 21 OTUs varied significantly with age (FDR<0.05). Some OTUs including Veillonella, Streptococcus, Bacteroides and Helicobacter were more abundant in children ≤ 1 year old compared to older children. Furthermore, the gut microbiome differed in schistosome infected vs. uninfected children with 27 OTU occurring in infected but not uninfected children, for 5 of these all Prevotella, the difference was statistically significant (p <0.05) with FDR <0.05. PZQ treatment did not alter the microbiome structure in infected or uninfected children from that observed at baseline. CONCLUSIONS: There are significant differences in the gut microbiome structure of infected vs. uninfected children and the differences were refractory to PZQ treatment. Public Library of Science 2015-06-26 /pmc/articles/PMC4482744/ /pubmed/26114287 http://dx.doi.org/10.1371/journal.pntd.0003861 Text en © 2015 Kay et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kay, Gemma Louise
Millard, Andrew
Sergeant, Martin J.
Midzi, Nicholas
Gwisai, Reggis
Mduluza, Takafira
Ivens, Alasdair
Nausch, Norman
Mutapi, Francisca
Pallen, Mark
Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children
title Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children
title_full Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children
title_fullStr Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children
title_full_unstemmed Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children
title_short Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children
title_sort differences in the faecal microbiome in schistosoma haematobium infected children vs. uninfected children
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4482744/
https://www.ncbi.nlm.nih.gov/pubmed/26114287
http://dx.doi.org/10.1371/journal.pntd.0003861
work_keys_str_mv AT kaygemmalouise differencesinthefaecalmicrobiomeinschistosomahaematobiuminfectedchildrenvsuninfectedchildren
AT millardandrew differencesinthefaecalmicrobiomeinschistosomahaematobiuminfectedchildrenvsuninfectedchildren
AT sergeantmartinj differencesinthefaecalmicrobiomeinschistosomahaematobiuminfectedchildrenvsuninfectedchildren
AT midzinicholas differencesinthefaecalmicrobiomeinschistosomahaematobiuminfectedchildrenvsuninfectedchildren
AT gwisaireggis differencesinthefaecalmicrobiomeinschistosomahaematobiuminfectedchildrenvsuninfectedchildren
AT mduluzatakafira differencesinthefaecalmicrobiomeinschistosomahaematobiuminfectedchildrenvsuninfectedchildren
AT ivensalasdair differencesinthefaecalmicrobiomeinschistosomahaematobiuminfectedchildrenvsuninfectedchildren
AT nauschnorman differencesinthefaecalmicrobiomeinschistosomahaematobiuminfectedchildrenvsuninfectedchildren
AT mutapifrancisca differencesinthefaecalmicrobiomeinschistosomahaematobiuminfectedchildrenvsuninfectedchildren
AT pallenmark differencesinthefaecalmicrobiomeinschistosomahaematobiuminfectedchildrenvsuninfectedchildren